Pricing Log in Create free account

bioAffinity Technologies, Inc. (BIAF) vs Inotiv, Inc. (NOTVQ)

bioAffinity Technologies, Inc. and Inotiv, Inc. are both Diagnostics & Research companies. bioAffinity Technologies, Inc. is the larger, with a market value of $5.1M against $2.8M — 1.8× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −23.2%. Inotiv, Inc. has the higher net margin (−17.1% vs −257.3%) and the higher return on invested capital (−6.19% vs −408.7%). Across the 18 metrics below, bioAffinity Technologies, Inc. leads on 9 and Inotiv, Inc. on 9.

Valuation

Metric BIAF NOTVQ Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.22 0.00 4.37
P/B 0.35 0.00 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA 0.05 60.99 24.35
EV/Sales (0.10) 1.57 5.51
Earnings yield (2,934.19%) (25,300.00%) (1.89%)
Free cash flow yield (889.05%) (2,858.05%) (0.15%)

Profitability

Metric BIAF NOTVQ Diagnostics & Research median
Gross margin 34.61% 22.94% 50.89%
Operating margin (209.82%) (9.48%) (8.57%)
Net margin (257.33%) (17.14%) (6.37%)
Free cash flow margin (195.90%) (1.95%) 0.00%
Return on equity (1,860.15%) (74.09%) (2.92%)
Return on assets (245.51%) (11.85%) (6.71%)
Return on invested capital (408.67%) (6.19%) 0.00%

Growth

Metric BIAF NOTVQ Diagnostics & Research median
Revenue growth (TTM) (23.18%) 5.61% 7.69%
EPS growth (last fiscal year) 61.55% 49.64% 25.92%
Revenue growth, 5-year CAGR — 53.36% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIAF NOTVQ Diagnostics & Research median
Debt to equity 0.15 5.49 0.11
Current ratio 1.44 0.27 2.02
Net debt to EBITDA 0.57 12.68 0.70

Dividend

Metric BIAF NOTVQ Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BIAF NOTVQ Diagnostics & Research median
Market cap 5.08m 2.79m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack